课题基金 / 基金详情

Project 1 Early Microbiota-Related Risk Factors and the Development of a Multi-Sensitized High Risk for Allergic Asthma Phenotype

Project 1 Early Microbiota-Related Risk Factors and the Development of a Multi-Sensitized High Risk for Allergic Asthma Phenotype
项目 1 早期微生物群相关危险因素和过敏性哮喘表型多敏高风险的发展
批准号:
10480069
负责人:
Christine C Johnson
金额:
$13.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
未结题
起止时间:
2012-07-06 至 2025-08-31

项目摘要

项目成果

Christine C Johnson的其他基金

相似基金

相关文献

中文摘要
翻译
我们儿童的健康状况对这个国家有着持久的社会和经济影响。哮喘 是美国儿科年龄段最常见的慢性病。这种病经常延续到 成年期,与终生肺功能缺陷有关。这些孩子中的大多数也是 过敏,还有一群人患有难以控制的哮喘。尽管做了大量的研究工作,但 在过去的几十年里,哮喘患病率的急剧上升并没有得到缓解。 新希望集中在调查影响和可能的干预机会的研究上 由对肠道微生物区系的研究提供。随着文化独立的出现,这已成为可能 技术我们最初的P01使用我们的WHEALS出生队列来证明许多孩子和 此外,母亲的特征与婴儿的肠道微生物群落组成有关。婴儿期 肠道微生物区系特征,如较低的细菌多样性和较高的真菌多样性,是相关的 2岁时有多变应原致敏(IgE)表型,4岁时有哮喘。我们的新数据显示 这个年龄2岁的表型与10岁时多敏性过敏性哮喘的高风险相关,以及 同样的肠道微生物区系特征与这种更高的风险相关。我们新的P01小鼠数据支持 母体微生物区系对后代免疫系统的影响。 WHEALS出生队列最初的设计并不是为了检查婴儿肠道微生物区系与 过敏,或母亲对这种联系的贡献。婴儿粪便样本是通过使用有限的 机构资金,因此只在一个或两个时间点,而且相对零星。该项目将 利用以卫生系统为基础的新的、大型和多样化的一般风险出生队列,重点研究 拥有最新样本收集和分析技术的肠道微生物区系,以及收集的粪便样本,请访问 更早和更频繁的婴儿时间点,一个在怀孕后期。我们建议对多个 在怀孕期间可能影响母体微生物区系的变量,这些影响与孩子的 过敏的风险,以及母婴肠道微生物如何调节风险。项目1是 旨在了解母婴暴露和肠道微生物及其与儿童肠道微生物的关系 2岁前有高度多敏感型或不敏感型(对敏感型有弹性)的风险。 总而言之,P01中的协调项目正在处理对未来具有高度信息量的假设 通过行为/社会或直接的方式制定与微生物相关的潜在预防干预措施 微生物手段。
英文摘要
The health status of our children has long lasting social and economic ramifications for the nation. Asthma is the most common chronic condition in the U.S. pediatric age group. This disease often carries on into adulthood and is associated with lifelong deficits in lung function. The majority of these children are also allergic, and a sub-group have asthma that is difficult to control. Despite substantial research effort, the dramatic increase in asthma prevalence over the past decades has not been mitigated. New hope is centered on research investigating the influence and possible interventional opportunities afforded by study of the gut microbiota. This has become possible with the advent of culture-independent technology. Our initial P01 used our WHEALS birth cohort to demonstrate that numerous child and also maternal characteristics were associated with the infant's gut microbiota community composition. Infant gut microbiota characteristics, such as lower bacterial diversity and higher fungal diversity, were associated with a multi-allergen-sensitized (IgE) phenotype at age 2 years and asthma at age 4 yrs. Our new data reveals that this age 2yr phenotype is associated with a high risk of multi-sensitized allergic asthma at age 10 yrs, and the same gut microbiota characteristics are associated with this higher risk. Our new P01 murine data supports a maternal microbiota influence on the offspring's immune system. The WHEALS birth cohort was not initially designed to examine how the infant gut microbiota is related to allergy, or the maternal contributions to this association. Infant stool samples were obtained using limited institutional funds and therefore at only one or two points in time and relatively sporadically. This Project will capitalize on a new, large and diverse health system-based general risk birth cohort with the focus of studying the gut microbiota with the latest sample collection and analytic techniques and collection of stool specimens at earlier and more frequent infant time points and one in late pregnancy. We propose detailed studies of multiple variables likely to affect the maternal microbiota during pregnancy, how these effects are related to the child's risk of allergic sensitization, and how the maternal and infant gut microbiotas can mediate risk. Project 1 is designed to home in on maternal/infant exposures and gut microbiotas and how they associate with the child's risk of becoming highly multi-sensitized or not sensitized (resilient to sensitization) by the age of 2 yrs. Altogether, the coordinated Projects in this P01 are addressing hypotheses highly informative to future development of potential microbial-related preventive interventions through both behavioral/social or direct microbial means.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Epidemiology and Response to SARS-CoV-2 (HEROS)
  • 批准号:
    10167014
  • 项目类别:
  • 资助金额:
    $6.57万
  • 财政年份:
    2020
  • 负责人:
    Christine C Johnson
  • 依托单位:
Pets and the Infant's Microbiome Exposures: Impac on Childhood Allergic Asthma
  • 批准号:
    9088338
  • 项目类别:
  • 资助金额:
    $23.2万
  • 财政年份:
    2016
  • 负责人:
    Christine C Johnson
  • 依托单位:
Personalizing Care for Obese Patients in an Urban Health System
  • 批准号:
    9340014
  • 项目类别:
  • 资助金额:
    $96.81万
  • 财政年份:
    2013
  • 负责人:
    Christine C Johnson
  • 依托单位:
Personalizing Care for Obese Patients in an Urban Health System
  • 批准号:
    8737239
  • 项目类别:
  • 资助金额:
    $98.14万
  • 财政年份:
    2013
  • 负责人:
    Christine C Johnson
  • 依托单位:
海外基金